WILMINGTON, Del., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A. announces that it is investigating GW Pharmaceuticals plc (“GW Pharmaceuticals”) (NASDAQ GM: GWPH) regarding possible breaches of fiduciary duties and other violations of law related to GW Pharmaceuticals’ agreement to be acquired by Jazz Pharmaceuticals plc (“Jazz Pharmaceuticals”) (NASDAQ GS: JAZZ). Under the terms of the agreement, GW Pharmaceuticals’ shareholders will receive $20.00 worth of shares of Jazz Pharmaceuticals and $200.00 in cash per share.
To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-gw-pharmaceuticals-plc.
You may also contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at (888) 969-4242 or firstname.lastname@example.org.
Rigrodsky Law, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.
Attorney advertising. Prior results do not guarantee a similar outcome.